Rubicon Research enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026
25,820—
186186
0.00.0
259259
25,894—
73.773.7
₹1,568.47—
1,5481,548
16.8%16.8%
0.01×—
13.38×—
57.51×—
64.83×—
Reference items — trailing FY values
1,9361,754
450400
399355
—205
−24.1−24.1
—−32.5
—229
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

RUBICON₹1,564.00

Rubicon Research Ltd.

· Pharma & Health
₹ CrorePeersSHILPAMEDSPARCSTARSUPRIYAPARKHOSPSTHYROCAREMETROPOLISMARKSANSMcap ₹25,820 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization—25,820.1
- Cash, Equiv & ST Investments185.7185.7
+ Minority Interest0.00.0
+ Total Debt259.4259.4
Enterprise Value—25,893.8
Net Debt (memo)73.773.7
EV per Share—1,568.47
Total Capital1,548.21,548.2
Total Debt/Total Capital16.7516.75
Total Debt/EV—0.01
EV/Sales—13.38
EV/EBITDA—57.51
EV/EBIT—64.83
Reference Items — Trailing FY Values
Sales1,754.01,935.8
EBITDA400.2450.2
EBIT355.0399.4
Operating Cash Flow205.0—
Free Cash Flow-24.1-24.1
FCFF (free cash flow to the firm)-32.5—
Capital Expenditure229.2—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.